Investing Profile

Steve Kafka

InvestorVC
Managing Partner at Section 32
s32.com/team/steve-kafkaCambridge, Massachusetts
Photo of Steve Kafka, Managing Partner at Section 32
cb
Section 32 Managing Partner
$10K - $50K
$25K
7
$740M
CompanyStageDateRound SizeTotal Raised
Function Oncology
Series AApr 2023$28M
$28M
Co-investors: Vineeta Agarwala (Andreessen Horowitz)
BigHat Biosciences
Series BJul 2022$75M
$94M
Co-investors: Vineeta Agarwala (Andreessen Horowitz), Andy Harrison (Section 32)
Satellite Bio
Series AMar 2022$82M
$100M
Co-investors: Ellie McGuire (Polaris Partners), Ling Wong (Highbury Group), Yair Schindel (aMoon Fund)
ROME Therapeutics
Series BSep 2021$77M
$130M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Kristina Burow (ARCH Venture Partners), Jim Trenkle (Sanofi Ventures)
ImmuneID
Series AJun 2021$50M
$67M
Co-investors: Christoph Westphal (Longwood Fund), Dan Janney (Alta Partners)
Thrive Earlier Detection
Series BJul 2020$260M
$370M
Co-investors: Neil Exter (Third Rock Ventures), Mike Pellini (Section 32)
Glympse Bio
Series BJul 2020$47M
$76M
Co-investors: George Zachary (CRV), Amy Schulman (Polaris Partners), Andrew Perlman (‎GreatPoint Ventures), Theresia Gouw (aCrew Capital)